This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign InLog Out ProductsOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysPfizer Dermatology Patient AccessExplore ContentEventsMaterialsVideosContact
Search

Menu

Close

About

About

Efficacy
MOA
Mist MomentsSafety & Dosing

Safety &
Dosing

SafetyDosing
Formulary CoverageSavings & Support

Practice Resources

Savings & Support OptionsPrior Authorization ResourcesMaterialsVideos
Prescribing InformationPatient Information Instructions for UseIndication Press Release
Savings & Support Options
Help your patients access ZAVZPRET with resources like the $0 copay card and Zavzpret OneSource savings and support program, as well as materials to guide the prior authorization process.
Copay Card and Retail Pharmacy FulfillmentShare this copay card information with your patients
  • Eligible patients with commercial insurance may pay as little as $0 per month*
  • Patients can download and activate a card to get started today by visiting ZAVZPRET.com/savings
Email copay card info Loading
Copay card
  • Eligible patients with commercial insurance may pay as little as $0 per month*
  • Patients can download and activate a card to get started today by visiting ZAVZPRET.com/savings

*Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico. The offer will be accepted only at participating pharmacies. This offer is not health insurance. No membership fees apply. Pfizer reserves the right to rescind, revoke, or amend this offer without notice. For any questions, please call 1-800-761-1568. For full terms and conditions, visit zavzpret.com/copay-terms or write to Pfizer Inc. at PO Box 29387, Mission, KS 66201.

One stop for resources and personalized patient support
Call 1-877-ZAVZPRET and a Zavzpret OneSource representative will assist you. Call nowLoading
Access for your eligible, commercially insured patients

Eligible patients may access ZAVZPRET at no cost while benefits are being verified

Eligible patients may access ZAVZPRET at no cost while benefits are being verified

Pay as little as $0 with the ZAVZPRET copay card*

Pay as little as $0 with the ZAVZPRET copay card*

*Eligible commercially insured patients can, for one time only, access ZAVZPRET at no cost while benefits are being verified for as many as two prescription fills, with a combined maximum of 12 devices total. Insurance coverage must be approved by the payor for patients to continue receiving ZAVZPRET with no out-of-pocket cost. No membership fees. Only available for commercially insured patients. This is not health insurance. The full terms and conditions can be accessed at zavzpret.com/copay-terms.


†As long as coverage is being investigated until the end of 2024. For 1 RX fill only.
No enrollment forms, just prescribe

ePrescribe: Select ASPN Pharmacies, LLC in your EMR

Patient Outreach: ASPN Pharmacies contacts patients within 2 hours

  • Give your patient a OneSource Intro Card so they know what to expect

Prescription Delivery: Shipped to patient's home or they can opt to pickup from their local pharmacy

Prior Authorization
CoverMyMeds® can help streamline the prior authorization process Get started nowLoadingTipHave your patient call their pharmacy first to ensure ZAVZPRET is in stock OR consider prescribing ZAVZPRET via Zavzpret OneSource.

Need help navigating the prior authorization process?

We've got tools and resources for you.

Explore resources Loading
Savings & Support Check local coverage

Use our formulary lookup tool to discover coverage options in your area.

Find coverage now Loading
Connect with a ZAVZPRET representative

Need additional information, samples, or copay cards? A product representative can assist you.

Request a representative Loading

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2024 Pfizer Inc. All rights reserved.

PP-ZAZ-USA-0452
You are now leaving PfizerPro

You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.
PP-MCL-USA-0367

INDICATION

ZAVZPRETTM (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Important Safety Information Contraindications: Hypersensitivity to ZAVZPRET or any of its components.

Warnings and Precautions: Hypersensitivity reactions, including facial swelling and urticaria, have occurred with ZAVZPRET. If a hypersensitivity reaction occurs, discontinue ZAVZPRET and initiate appropriate therapy.

Adverse Reactions: Most common adverse reactions (occurring in ≥2% of patients treated with ZAVZPRET and greater than placebo) for ZAVZPRET vs placebo were taste disorders including dysgeusia and ageusia (18% vs 4%), nausea (4% vs 1%), nasal discomfort (3% vs 1%), and
vomiting (2% vs <1%).

Drug Interactions: Avoid use with drugs that inhibit or induce OATP1B3 or NTCP transporters. Avoid use of intranasal decongestants; if unavoidable, administer intranasal decongestants at least 1 hour after ZAVZPRET administration.

Use in Specific Populations:
Pregnancy: It is not known if ZAVZPRET can harm an unborn baby. Lactation: It is not known whether ZAVZPRET passes into breast milk. Hepatic Impairment: Avoid use in patients with severe hepatic impairment. Renal impairment: Avoid use of ZAVZPRET in patients with creatinine clearance (CLcr) less than 30 mL/min.

Please click here for full Prescribing Information.
IndicationZAVZPRET™ (zavegepant) is indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use: ZAVZPRET is not indicated for the preventive treatment of migraine.

Please see Full Prescribing Information.